Puretech Health Plc (PRTCL)

117.00p
   
  • Change Today:
    -0.054p
  • 52 Week High: 139.80
  • 52 Week Low: 107.90
  • Currency: UK Pounds
  • Shares Issued: 237.39m
  • Volume: 53,263
  • Market Cap: £277.74m

PRTCL Overview

PureTech Health plc (“PureTech Health”, “PureTech” or “the Company”) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

Key Personnel

CEO: Robert Lyne
Independent Non-Executive Director: John LaMattina
Independent Non-Executive Director: Kiran Mazumdar Shaw
Independent Non-Executive Director: Michele Holcomb
Interim Chairman: Sharon Barber-Lui
Non-Executive Dir: Robert Langer, H. Robert Horvitz

Contact Details

Address: 6 Tide St Ste 400, Boston, United States, MA, 02210
Phone: +1 617 482 2333
Website: http://www.puretechhealth.com

Listings

Overseas Listings: LSE:PRTC
ISIN: GB00BY2Z0H74

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

PRTCL Market Data

Currency UK Pounds
Share Price 117.00p
Change Today -0.054p
% Change -4.41 %
52 Week High 139.80
52 Week Low 107.90
Volume 53,263
Shares Issued 237.39m
Market Cap £277.74m

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 06-Nov-2026

Time Volume / Share Price
13:30 547 @ 117.00p
13:26 86 @ 117.20p
13:01 800 @ 117.20p
13:00 633 @ 117.20p
13:00 56 @ 117.20p

PRTCL Key Personnel

CEO Robert Lyne

Top of Page